Abstract CT202: Xevinapant Plus Avelumab in Patients (pts) with Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC): Phase 1b Dose-Expansion Results and Exploratory Biomarker Analyses
Cancer Research(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要